By Zachary Zagger ( May 2, 2014, 8:56 PM EDT) -- Investment banking advisory firm Peter J. Solomon Co. is suing a British biotech company, formerly known as Spirogen Ltd., seeking $3.75 million in fees for advising the company in its $200 million sale to an AstraZeneca PLC subsidiary, according to a complaint filed in New York court Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.